High Court Lets Teva Drug Labeling Suit Go Ahead

Law360, Los Angeles (January 20, 2015, 6:01 PM EST) -- The U.S. Supreme Court refused Tuesday to hear an appeal by Teva Pharmaceuticals USA Inc. and other generic-drug makers of a ruling allowing a state failure-to-warn suit to proceed, potentially paving the way for similar cases against other generics makers.

Without providing reasoning for its decision, as is customary in its petition denials, the Supreme Court rejected Teva’s bid to overturn a California appellate court’s decision to let the case go forward.

In June 2013, the California Court of Appeal for the Fourth Appellate District backed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.